We are live on ! Find out more
TRIV

TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV

Delisted

TRIV was delisted on the 3rd of February, 2016.

41 hedge funds and large institutions have $169M invested in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 11

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

0% more funds holding

Funds holding: 4141 (0)

7% less capital invested

Capital invested by funds: $181M → $169M (-$12.4M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
41
Holders Change
Holders Change %
0%
% of All Funds
1.09%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
3
Increased
19
Reduced
11
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NMC
1
NEA Management Company
Maryland
$49.6M
MAM
2
MPM Asset Management
Massachusetts
$22.3M
RG
3
Redmile Group
California
$22.1M +$55.2K +4,050 +0.2%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$20.1M +$1.67M +122,400 +8%
DM
5
Deerfield Management
New York
$14.4M -$5.24M -383,956 -25%
Stifel Financial
6
Stifel Financial
Missouri
$12.6M
Wellington Management Group
7
Wellington Management Group
Massachusetts
$11M +$3.28M +240,621 +38%
BFA
8
BlackRock Fund Advisors
California
$2.56M +$388K +28,460 +16%
RSCM
9
Rock Springs Capital Management
Maryland
$2.49M +$2.7M +198,000 New
DCM
10
Driehaus Capital Management
Illinois
$1.63M +$38.4K +2,818 +2%
JP Morgan Chase
11
JP Morgan Chase
New York
$1.5M -$16.7K -1,225 -1%
Vanguard Group
12
Vanguard Group
Pennsylvania
$1.46M +$756K +55,439 +92%
Allianz Asset Management
13
Allianz Asset Management
Germany
$961K -$10.6K -775 -1%
Northern Trust
14
Northern Trust
Illinois
$912K -$13.4K -986 -1%
USAA
15
United Services Automobile Association
Texas
$775K +$38.7K +2,840 +5%
State Street
16
State Street
Massachusetts
$761K +$527K +38,653 +178%
BIT
17
BlackRock Institutional Trust
California
$758K -$51.3K -3,761 -6%
Goldman Sachs
18
Goldman Sachs
New York
$563K -$16.2K -1,188 -3%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$404K +$3.56K +261 +0.8%
BCM
20
Bridgeway Capital Management
Texas
$382K +$4.09K +300 +1%
TCIM
21
TIAA CREF Investment Management
New York
$341K +$9.63K +706 +3%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$325K -$1.19K -87 -0.3%
BIM
23
BlackRock Investment Management
Delaware
$274K +$873 +64 +0.3%
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$173K +$805 +59 +0.4%
Charles Schwab
25
Charles Schwab
California
$138K

TRIV Hedge Fund Activity: Q4 2014 in Review

41 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) for Q4 2014, worth a combined $169M — down 6.9% from $181M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new TRIV positions and 2 closed out — a net gain of 1 holder — while 19 added to existing stakes and 11 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $3.28M. The largest seller was Deerfield Management, cutting an estimated $5.24M.

  • 41 institutional investors held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) as of Q4 2014, unchanged from Q3 2014.
  • Funds reported $169M of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK stock for Q4 2014, down 6.9% quarter-over-quarter.
  • 3 funds opened new TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK positions in Q4 2014 and 2 closed out, a net change of +1 holder.
  • The largest TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK buyer in Q4 2014 was Wellington Management Group, an estimated $3.28M added.
  • The largest TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK seller in Q4 2014 was Deerfield Management, an estimated $5.24M sold.

Based on aggregated 13F filings for Q4 2014.